Thrombotic risk in thalassemic patients

Journal of Pediatric Endocrinology and Metabolism

Volumn 11, Issue SUPPL. 3, 1998, Pages 915-921

  Moratelli, S ^a   De Sanctis, V ^b   Gemmati, D ^a   Serino, M L ^a   Mari, R ^a   Gamberini, M R ^b   Scapoli, G L ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b S ANNA HOSPITAL   (Italy)

Author keywords

Risk factors; Thalassemia; Thrombosis

Indexed keywords

ESTROGEN; GESTAGEN;

ADOLESCENT; ADULT; BETA THALASSEMIA; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HORMONAL THERAPY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; SPLENECTOMY; THALASSEMIA MAJOR; THALASSEMIA MINOR; THROMBOCYTOSIS; THROMBOEMBOLISM; THROMBOPHILIA; THROMBOSIS;

ADOLESCENT; ADULT; ATRIAL FIBRILLATION; BETA-THALASSEMIA; CEREBRAL INFARCTION; CHILD; DIABETES MELLITUS, TYPE 1; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PULMONARY EMBOLISM; RISK FACTORS; SPLENECTOMY; THROMBOSIS;

EID: 0032425115     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Helley D, Eldor A, Girot R, Ducrocq R, Guillin MC, Bezeaud A, Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and β-thalassemia. Thromb Haemost 1996; 76: 322-327.
2. Borenstein V, Barenholz Y, Hy-Am E, Rachmilewitz EA, Eldor A. Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol 1993; 44: 63-65.
3. Connor J, Pack CC, Schroit AJ. Exposure of phosphatidylserine in the outer leaflet of human red blood cells. Relationship to cell density, cell age and clearance by mononuclear cells. J Biol Chem 1994; 269: 2399-2404.
4. Eldor A, Lellouche F, Goldfarb A, Rachmilewitz EA, Maclouf J. In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites. Blood 1991; 77: 1749-1753.
5. Francis RB. Platelets, coagulation and fibrinolysis in sickle cell disease: their possible role in vascular occlusion. Blood Coag Fibrinol 1991; 2: 341-353.
6. Kurantsin-Mills J, Ofosu FA, Safa TK, Siegel RS, Lessin LS. Plasma factor VII and thrombinantithrombin III levels indicate increased tissue factor activity in sickle cell patients. Br J Haematol 1992; 81: 539-544.
7. Sonakul D, Pacharee P, Laohapand T, Fucharoen S, Wasi P. Pulmonary artery obstruction in thalassemia. South Asian J Trop Med Pub Hlth 1990; 11: 516-523.
8. Peters M, Plaat BEC, Ten Gate H, Wolters HJ, Weening RS, Brandjes DPM. Enhanced thrombin generation in children with sickle cell disease. Thromb Haemost 1994; 71: 169-172.
9. Shirahata A, Funahara Y, Opartkiattikul N, Fucharoen S, Laosombat V, Yamada K. Protein C and protein S deficiency in thalassemic patients. South Asian J Trop Med Pub Hlth 1992; 23 (Suppl 2): 65-73.
10. Skarsgard E, Doski J, Jaksic T, Wesson D, Shandling B, Ein S, Babyn P, Heiss K, Hu X. Thrombosis of the portal venous system after splenectomy for pediatric hematologic disease. J Pediatr Surg 1993; 28: 1109-1112.